121. MDMA / Ecstasy : Utopian Pharmacology Lifelong Ecstasy? Beyond MDMA. Mental Health in the Third Millennium; drugs and medications. http://www.mdma.net/

UTOPIAN PHARMACOLOGY Mental Health in the Third Millennium MDMA and Beyond MDMA/Ecstasy A brief history of MDMA The MDMA Experience MDMA : neurotoxicity ... Beyond MDMA : mental superhealth MDMA/Ecstasy Can safe, sustainable analogues of MDMA be developed? There is an urgent need for non-neurotoxic empathogens and entactogens suitable for lifelong use. Alas no single "magic bullet" yet exists that replicates the subjective effects of MDMA on a long-term A brief history of MDMA MDMA [3,4-methylenedioxy-methamphetamine: ' Ecstasy '] was first synthesized in 1912 by the German pharmaceutical company Merck . MDMA was patented in Darmstadt, Germany on May 16th 1914, issue number 274,350; and promptly forgotten. Merck's researchers had no idea of the significance of what they had done. Merck were searching for a good vasoconstrictor, a styptic to reduce bleeding. In 1912 two of their chemists, G. Mannish and W. Jacobsohn, created MDMA as a by-product while attempting to synthesise hydrastinin. MDMA is listed on Merck's patent-application merely as a chemical intermediate "for products of potential pharmaceutical value". MDMA surfaced again briefly as one of a number of agents used in clandestine US military research during the 1950s. The

122. Pharmacology And Physiology The Department of pharmacology and Physiology of the University of Rochester Medical Center investigates and teaches mechanisms of drug action and of integrative cellular and molecular biology. Studies lead to a Ph.D. degree. http://www.urmc.rochester.edu/phph/graduate/index.html

Home Faculty Graduate Students Postdoctoral Fellows ... Cellular and Molecular Basis of Medicine Cluster (CMM) Graduate Program in Pharmacology and Physiology Ph.D. Degree Programs The graduate programs at the University of Rochester School of Medicine and Dentistry have been restructured to form the Graduate Education in the Biomedical Sciences (GEBS) program. There are ten graduate clusters in GEBS, and the cluster most associated with the Department of Pharmacology and Physiology is the Cellular and Molecular Basis of Medicine. The clusters are responsible for recruiting prospective students and for mentoring them during their first year of study. First-year graduate students take core courses in biochemistry, molecular biology, cell biology, and ethics along with elective courses and complete three research rotations, but are not required to declare a major subject. At the end of their first year, students select a major subject and a thesis advisor. Graduate Program in Pharmacology and Physiology The objective of the graduate program in Pharmacology and Physiology at the University of Rochester is to train scientists in molecular and integrative pharmacology and physiology who are well prepared for careers in independent research and teaching. The program offers Ph.D. degrees in both pharmacology and physiology and includes courses in basic and advanced biomedical sciences, pharmacology, and physiology; original laboratory research; and the preparation and defense of a doctoral thesis.

123. University Of Oxford Dept Of Pharmacology: Home Page University of Oxford Dept of pharmacology Home page. http://www.pharm.ox.ac.uk/

University of Oxford Department of Pharmacology About Us Teaching Seminars Brochure* ... Search * Note: This is a link to a pdf file, you will need Adobe Acrobat software to view this. MSc Taught Course Page owner: Webmaster (email: it@pharm.ox.ac.uk ). Page last updated on Feedback about the web site to: webmaster (email: it@pharm.ox.ac.uk)

124. IKP (1977 - 2005) Conducting Phase 1 through Phase 4 multinational clinical studies. Facilities include three specialized Phase 1 clinical pharmacology units and bioanalytical laboratories. http://www.ikp.de

Institut für klinische Pharmakologie (IKP-Bobenheim) Contract Research Organization (CRO) Clinical Studies Phase I-II years of successful business Best view with MS IE 6.0 (1152 x 864)

125. The Department Of Pharmacology At The University Of Texas Health Science Center The Department of pharmacology at The University of Texas Health Science Center at San Antonio. http://pharmacology.uthscsa.edu/

What is Pharmacology Faculty Graduate Program Admissions ... Postdoctoral Positions Available Graduate School of Biomedical Sciences 7703 Floyd Curl Drive San Antonio TX 78229-3900 Links provided from Health Science Center pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites. For suggestions, comments, and concerns about this site, e-mail us at: webteam@uthscsa.edu

126. Home Page Manufactures and supplies systems and software for laboratories of pharmacology, physiology and biophysics. http://www.commat.com.tr

Pharmacology, Physiology and Biophysics Instrumentation Home About Us Products Representative ... References News Below is the list of congresses and meetings that Commat will participate as sponsor in 2005. 02-04 March 2005 Pharmacology Winter Meeting Scientific Interaction between the generations in Pharmacology Education Ankara- TURKEY 29 March - 02 April 2005 National Neurosciences Congress Mersin - TURKEY 01-03 September 2005 National Biophysics Congress Izmir- TURKEY 27-30 September 2005 31th National Physiology Congress Gaziantep - TURKEY 28 September – 1 October 2005 Turkish Pharmocology Association, 18th National Pharmacology Congress Izmir -TURKEY COMMAT manufactures and supplies high-quality systems and software for laboratories of pharmacology, physiology and biophysics. Biopac Student Lab for Physiology Education Biomedical Engineering Tissue Baths ... Contact Us

127. Redirect http://www.unmc.edu/Pharmacology/

128. Lithium Carbonate, Eskalith, Lithane, Lithobid Pharmacology - HealthyPlace.com Information sheet covers description, pharmacology, uses, dosage, side effects, and other advice for patients. http://www.healthyplace.com/medications/lithium.htm

Lithium Carbonate Brand Names: Eskalith; Eskalith-Cr; Lithane; Lithobid; Lithonate; Lithotabs outside U.S., Brand Names also known as: Calith; Camcolit; Carbolit; Carbolith; Ceglution; Ceglution 300; Duralith; Hypnorex; Hynorex Retard; Hyponrex; Lentolith; Licab; Licarb; Licarbium; Lidin; Lilipin; Lilitin; Limas; Liskonum; Lithan; Litheum; Litheum 300; Lithicarb; Lithionate; Lithizine; Lithocarb; Lithocap; Lithosun SR; Lithuril; Litilent; Manialit; Maniprex; Phanate; Phasal; Plenur; Priadel; Priadel Retard; Quilonium-R; Quilonorm Retardtabletten; Quilonum Retard; Teralithe; Theralite; Theralite 300 Contents: Description Pharmacology Indications and Usage Contraindications ... Supplied Description Lithium is an antipsychotic, antimanic medication used for those with Affective Disorder, Bipolar; Bipolar Disorder Depression; Mania . (Lithium medications may also go by the brand names: Eskalith, Eskalith-Cr, Lithane, Lithium, Lithobid, Lithonate, Lithotabs.) Pharmacology Lithium is an element of the alkali-metal group. Preclinical studies have shown that lithium alters sodium transport in nerve and muscle cells and effects a shift toward intraneuronal metabolism of catecholamines, but the specific biochemical mechanism of lithium action in mania is unknown. Indications and Usage Lithium carbonate is indicated in the treatment of manic episodes of manic-depressive illness . Maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania.

129. Error 404: Page Not Found Teaching of medical and graduate students, with research programs in normal growth and differentiation, development and pathology of the nervous system, and mechanisms of normal and abnormal functions of several key hormones. http://www.med.nyu.edu/Pharm/about.html

NYU Medical Center Home NYU School of Medicine Home Research Home Administration ... Calendars The document you requested could not be found. Here are some possible reasons why: Due to our recent improvements, the page has a new name. You may have typed the page address incorrectly. To find what you need you can: Search our site by typing in a few keywords in the search box below. Visit our Home page Please contact the webmaster to report any broken link that is found within this website. Enter Search Key Words Below: NYU Medical Center NYU School of Medicine Research at NYU Administration ... Contact Webmaster

130. Behavioural Pharmacology Behavioural pharmacology An International Forum in Which Behaviour and pharmacology Receive Equal Attention Neurology Neuroscience Nursing pharmacology http://www.lww.com/product/?0955-8810

131. Department Of Biological Chemistry And Molecular Pharmacology Research, postdoc resources, image galleries for faculty members and contacts at Cambridge, Massachusetts. http://bcmp.med.harvard.edu/

@import url(http://bcmp.med.harvard.edu/components/com_htmlarea3_xtd-c/htmlarea.css) HTMLArea.loadPlugin("EnterParagraphs"); HTMLArea.loadPlugin("ContextMenu"); HTMLArea.loadPlugin("CSS"); var editor = null; Saturday, September 24, 2005 Home About Us People Research ... Contact Us W elcome to the Department of Biological Chemistry and Molecular Pharmacology (BCMP) at Harvard Medical School. BCMP is host to a broad range of education, research, and outreach programs in medical and basic research. Our goal is to understand the molecular mechanisms that underlie basic biological processes and how they go wrong in disease. The department specializes in the use, development, and teaching of fundamental principles in molecular, chemical, and structural biology. Click HERE to register for BCMP Retreat 2005 Today's Events No events today Recent Publications Upcoming Events Room Scheduling Admin Forms ... BCMP info

132. Lithium Carbonate Internet Mental Health discussion covers pharmacology, indications and contraindications, precautions, dosage, and other topics. From a Canadian monograph. http://www.mentalhealth.com/drug/p30-l02.html

Lithium Carbonate Brand names: Carbolith, Cibalith-S, Duralith, Eskalith, Lithane, Lithizine, Lithobid, Lithonate, Lithotabs Drug monograph Contents Summary Pharmacology Indications Contraindications ... Research Summary CARBOLITH Lithium Carbonate Use: Treatment of manic episodes of manic-depressive illness. Initiate treatment at 600-900 mg/day in 3 divided doses; increase to 1,200-1,800 mg/day in 3 divided doses to achieve serum lithium concentrations between 0.8 and 1.2 mmol/L. Adjust dose according to clinical response and trough serum level (12 h) after steady state is reached (4-5 days). After the acute manic episode subsides, adjust dose to maintain a level of 0.6-1.0 mmol/L. The average dosage range at this stage is usually 450-1,200 mg/day. If a satisfactory antimanic response is not obtained in 14 days, consider discontinuing lithium. Once patients are stabilized on a maintenance dose with a multiple dosing schedule and once stable therapeutic blood levels are reached, consider a once-daily dosage regimen. The total daily dose, when given as a single dose, may be about 5-30% lower than when given in divided doses over the day. Geriatrics: Starting dose should not exceed 300 mg/day accompanied by frequent serum level monitoring (concentrations should not exceed 1 mmol/L; usual range: 600-1,200 mg/day).

133. NRC Research Press: Canadian Journal Of Physiology And Pharmacology Canadian Journal of Physiology and pharmacology. Contents Sample Issue For Authors Information Services Copyright Conditions of Use http://pubs.nrc-cnrc.gc.ca/cgi-bin/rp/rp2_desc_e?cjpp

134. Medical Pharmacology Basic and applied medical pharmacology. Includes content, practice questions and clinical cases. http://www.kumc.edu/instruction/alliedHealth/NurseAnesthesia/Medical_Pharmacolog

Medical Pharmacology and Disease-Based Integrated Instruction This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Exit Pharmacology content Michael Gordon, Ph.D., site developer, Associate Professor, University of Kansas Medical Center

135. Dept. Of Medical Pharmacology & Physiology - The Department Here at MU, the pharmacology Faculty is actively involved in studying the regulation, The Medical pharmacology and Physiology Department and its modern http://www.muhealth.org/~mpp/

The Department In very broad terms, pharmacology is the study of interactions of chemicals with living organisms to produce biological effects. When such chemical interactions are applied to the treatment or cure of disease, the chemicals are often called drugs. Pharmacology is concerned with all aspects of chemicals interacting with biological systems - from the molecular level to the whole body. Thus, pharmacology relies on knowledge of physiology, biochemistry, molecular biology, and other scientific disciplines to understand how drugs produce their effects. A fundamental concept of pharmacology is that drugs bind to receptors to produce cellular responses. The observation that certain drugs interact with endogenous receptor molecules has led to the identification of the naturally-occurring neurotransmitters, hormones, or chemicals which activate that receptor and regulate a physiological response. Here at MU, the Pharmacology Faculty is actively involved in studying the regulation, expression, and identification of receptors, neurotransmitters, hormones, growth factors, other chemicals and the transmembrane signal transduction process which modulate ion transport, and regulate proliferation, differentiation, and apoptosis (programmed cell death).

136. Nicotine Conference - Presentation Summaries Conference on nicotine addiction and tobacco products. All proceedings online. Includes papers on nicotine delivery systems; pharmacology of nicotine; ethnicity, gender, and risk factors for smoking initiation; economics; advertising and promotion; prevention programs; individual differences; and intervention and treatment strategies. http://www.nida.nih.gov/meetsum/nicotine/SummaryIndex.html

SELECT A TOPIC... Acid/LSD Alcohol Club Drugs Cocaine Ecstasy/MDMA Heroin Inhalants Marijuana Methamphetamine PCP/Phencyclidine Prescription Medications Smoking/Nicotine Steroids (Anabolic) RELATED TOPICS Drug Testing Medical Consequences Prevention Research Treatment Research Trends and Statistics Addicted to Nicotine A National Research Forum Index of Presentation Summaries [Also see the Program Agenda for additional information. Many of the speaker's slides will be available for viewing online in the future.] Section I: History and Pharmacology Nicotine Delivery Systems John Slade, M.D. Robert Wood Johnson Medical School University of Medicine and Dentistry of New Jersey Pharmacology of Nicotine Jack E. Henningfield, Ph.D. Section II: Nicotine-Individual Risk Factors for Initiation Ethnicity, Gender and Risk Factors for Smoking Initiation Robin Mermelstein, Ph.D. Health Research and Policy Center University of Illinois at Chicago Child and Adolescent Psychopathology as Risk Factors for Tobacco Use Robert J. McMahon, Ph.D. Child Clinical Psychology Program University of Washington The Genetic Epidemiology of Smoking Kenneth S. Kendler, M.D.

137. University Of Washington--Dept Of Pharmacology University of Washington Department of pharmacology Home Page. http://depts.washington.edu/phcol/

//Top Navigational Bar III v3.4.1.1b (By BrotherCake @ cake@brothercake.net) //Permission granted/modified by Dynamicdrive.com to include script in archive //For this and 100's more DHTML scripts, visit http://www.dynamicdrive.com/ //This notice MUST stay intact for legal use Welcome to the University of Washington Department of Pharmacology. Department of Pharmacology - University of Washington Seattle WA Phone: (206) 543-1970 Fax: (206) 685-3822 E-Mail: phcol@u.washington.edu

138. Dyazide Online, Description, Chemistry, Ingredients - Hydrochlorothiazide And Tr Information from the RxList about this combination medication, marketed as Dyazide. Includes dosage, pharmacology, side effects, drug interactions, contraindications, and warnings. http://www.rxlist.com/cgi/generic/hctztri.htm

document.writeln(''); document.writeln(''); Hydrochlorothiazide and Triamterene document.writeln(''); document.writeln(''); Company Issues Pacemaker Malfunction Warning Deaths Seen With Fentanyl Narcotic Pain Patch FDA Reviews Adult Antidepressant-Suicide Link capsules diuretic WARNING Abnormal elevation of serum potassium levels (greater than or equal to 5.5 mEq/liter) can occur with all potassium-sparing diuretic combinations, including hydrochlorothiazide; triamterene. Hyperkalemia is more likely to occur in patients with renal impairment and diabetes (even without evidence of renal impairment), and in the elderly or severely ill. Since uncorrected hyperkalemia may be fatal, serum potassium levels must be monitored at frequent intervals especially in patients first receiving hydrochlorothiazide; triamterene, when dosages are changed or with any illness that may influence renal function.

139. Department Of Pharmacology At UCL pharmacology, University College London, Research and Teaching in Medical Sciences, Biomedicine. http://www.ucl.ac.uk/Pharmacology/

@import url(/css/fonts.css); @import url(/css/extras.css); UCL DEPARTMENT OF PHARMACOLOGY Prospective Students Current Students / Teaching Pharmacology - the subject The Department ... Home Page All Enquiries, Tel: The Department of Pharmacology at University College London was the first Pharmacology Department to be established in England in 1905. Mainly housed in a Grade II listed building but with several areas completely refurbished in 2005, it provides excellent facilities for teaching and research in Pharmacology. It is the only Department in the UK to have been rated in the top category in all five UGC/HEFCE research assessment exercises to date, and was the top-ranked (5 star A) Department in the last two exercises in 1996 and 2001. The rest of the Department is housed in the second floor of the Medawar Building and in the top two floors of the new Andrew Huxley building. Our Laboratory for Molecular Pharmacology is situated in the Medical Research Council (MRC) building adjacent to the main department. Student links to access course lists and information.

140. Nat' Academies Press, Clearing The Smoke: Assessing The Science Base For Tobacco Online book runs to 700 pages and has chapters on harm reduction, tobacco products, nicotine pharmacology, tobacco smoke and toxicology, cancer, heart disease, birth defects, and tobacco industry marketing of health claims. http://books.nap.edu/books/0309072824/html/index.html

Read more than 3,000 books online FREE! More than 900 PDFs now available for sale HOME ABOUT NAP CONTACT NAP HELP ... ORDERING INFO Items in cart [0] TRY OUR SPECIAL DISCOVERY ENGINE Questions? Call 888-624-8373 Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction (2001) Institute of Medicine ( IOM Find More Like This Book Research ... Dashboard NEW! BUY This Book CHAPTER SELECTOR: Openbook Linked Table of Contents Front Matter, pp. i-xx Executive Summary, pp. 1-18 1 Introduction, pp. 19-37 2 Principles of Harm Reduction, pp. 38-59 3 Historical Perspective and Lessons Learned, pp. 60-81 4 Products for Tobacco Exposure Reduction, pp. 82-139 5 The Scientific Basis for Pres Assessment, pp. 140-179 6 Surveillance for the Health and Behavioral Consequences o..., pp. 180-200 7 Implementation of a Science-Based Policy of Harm Reductio..., pp. 201-230 8 Principal Conclusions, pp. 231-240 9 Nicotine Pharmacology, pp. 241-282 10 Tobacco Smoke and Toxicology, pp. 283-308 11 Exposure and Biomarker Assessment in Humans, pp. 309-366

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 7     121-140 of 174    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8  | 9  | Next 20